http://www.prnewswire.com/rss/health/clinical-trials-medial-discoveries-news.rss/ Press Releases from PR Newswire about Clinical Trials & Medical Discoveries en-us Sun, 19 May 2013 04:05:09 EDT Sat, 18 May 2013 12:00:00 EDT http://www.prnewswire.com/news-releases/takeda-and-lundbeck-present-results-from-pivotal-phase-3-clinical-trials-with-vortioxetine-an-investigational-compound-for-major-depressive-disorder-207999231.html http://www.prnewswire.com/news-releases/takeda-and-lundbeck-present-results-from-pivotal-phase-3-clinical-trials-with-vortioxetine-an-investigational-compound-for-major-depressive-disorder-207999231.html Sat, 18 May 2013 12:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-study-shows-full-spectrum-endoscopy-procedure-reduces-the-miss-rate-of-adenomas-during-colonoscopy-207993801.html http://www.prnewswire.com/news-releases/new-study-shows-full-spectrum-endoscopy-procedure-reduces-the-miss-rate-of-adenomas-during-colonoscopy-207993801.html Sat, 18 May 2013 10:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/cardiodx-announces-new-data-demonstrating-use-of-corus-cad-in-the-primary-care-setting-for-evaluation-of-symptomatic-patients-with-suspected-cad-influences-clinical-decision-making-207870071.html http://www.prnewswire.com/news-releases/cardiodx-announces-new-data-demonstrating-use-of-corus-cad-in-the-primary-care-setting-for-evaluation-of-symptomatic-patients-with-suspected-cad-influences-clinical-decision-making-207870071.html Fri, 17 May 2013 11:00:00 EDT PALO ALTO, Calif., May 17, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a clinical utility study of the Corus® CAD gene expression test in the real-world primary care setting for evaluating patients with...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/shire-to-present-scientific-data-across-a-range-of-psychiatric-disorders-at-american-psychiatric-association-annual-meeting-207861511.html http://www.prnewswire.com/news-releases/shire-to-present-scientific-data-across-a-range-of-psychiatric-disorders-at-american-psychiatric-association-annual-meeting-207861511.html Fri, 17 May 2013 10:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/boston-scientific-presents-clinical-data-at-digestive-disease-week-207854381.html http://www.prnewswire.com/news-releases/boston-scientific-presents-clinical-data-at-digestive-disease-week-207854381.html Fri, 17 May 2013 09:01:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/cellular-biomedicine-group-achieves-50-enrollment-milestone-in-phase-i-clinical-trial-for-knee-osteoarthritis-207852201.html http://www.prnewswire.com/news-releases/cellular-biomedicine-group-achieves-50-enrollment-milestone-in-phase-i-clinical-trial-for-knee-osteoarthritis-207852201.html Fri, 17 May 2013 08:44:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/boehringer-ingelheim-to-present-17-abstracts-at-the-annual-american-thoracic-society-international-conference-207851261.html http://www.prnewswire.com/news-releases/boehringer-ingelheim-to-present-17-abstracts-at-the-annual-american-thoracic-society-international-conference-207851261.html Fri, 17 May 2013 08:35:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/sanofi-reports-positive-topline-results-from-pivotal-phase-iii-jakarta-study-for-jak2-inhibitor-in-myelofibrosis-207847641.html http://www.prnewswire.com/news-releases/sanofi-reports-positive-topline-results-from-pivotal-phase-iii-jakarta-study-for-jak2-inhibitor-in-myelofibrosis-207847641.html Fri, 17 May 2013 08:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/oramed-receives-fda-clearance-to-initiate-oral-insulin-trials-in-the-us-207846851.html http://www.prnewswire.com/news-releases/oramed-receives-fda-clearance-to-initiate-oral-insulin-trials-in-the-us-207846851.html Fri, 17 May 2013 07:50:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/insero-health-reports-positive-data-on-phase-i-trial-of-novel-therapy-for-drug-resistant-epilepsy-207845211.html http://www.prnewswire.com/news-releases/insero-health-reports-positive-data-on-phase-i-trial-of-novel-therapy-for-drug-resistant-epilepsy-207845211.html Fri, 17 May 2013 07:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/boston-scientific-schedule-of-major-events-and-presentations-at-europcr-2013-207832751.html http://www.prnewswire.com/news-releases/boston-scientific-schedule-of-major-events-and-presentations-at-europcr-2013-207832751.html Fri, 17 May 2013 03:01:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-study-shows-effect-of-neupro-rotigotine-transdermal-system-on-cardiovascular-measures-in-patients-with-restless-legs-syndrome-207829641.html http://www.prnewswire.com/news-releases/new-study-shows-effect-of-neupro-rotigotine-transdermal-system-on-cardiovascular-measures-in-patients-with-restless-legs-syndrome-207829641.html Fri, 17 May 2013 02:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/abbvie-and-galapagos-extend-glpg0634-collaboration-to-include-crohns-disease-207828201.html http://www.prnewswire.com/news-releases/abbvie-and-galapagos-extend-glpg0634-collaboration-to-include-crohns-disease-207828201.html Fri, 17 May 2013 01:15:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/astar-and-cytos-bring-singapores-first-influenza-vaccine-to-clinical-testing-207825891.html http://www.prnewswire.com/news-releases/astar-and-cytos-bring-singapores-first-influenza-vaccine-to-clinical-testing-207825891.html Fri, 17 May 2013 01:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/inspiremd-to-announce-six-month-results-from-the-mguard-embolic-protection-stent-eps-master-trial-at-europcr-207777001.html http://www.prnewswire.com/news-releases/inspiremd-to-announce-six-month-results-from-the-mguard-embolic-protection-stent-eps-master-trial-at-europcr-207777001.html Thu, 16 May 2013 17:24:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/eisai-highlights-new-research-on-melanoma-breast-and-endometrial-cancer-at-asco-annual-meeting-207762351.html http://www.prnewswire.com/news-releases/eisai-highlights-new-research-on-melanoma-breast-and-endometrial-cancer-at-asco-annual-meeting-207762351.html Thu, 16 May 2013 16:00:00 EDT WOODCLIFF LAKE, N.J., May 16, 2013 /PRNewswire/ -- Eisai Inc. announced today that nine abstracts highlighting new study results in melanoma, breast and endometrial cancer will be presented during the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/actinium-pharmaceuticals-clinical-results-to-be-presented-at-8th-international-symposium-on-targeted-alpha-therapy-conference-207719521.html http://www.prnewswire.com/news-releases/actinium-pharmaceuticals-clinical-results-to-be-presented-at-8th-international-symposium-on-targeted-alpha-therapy-conference-207719521.html Thu, 16 May 2013 11:41:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/helsinn-group-y-eisai-inc-anuncian-los-resultados-de-primera-linea-para-ensayos-pivote-con-netupitant-y-palonosetron-207717391.html http://www.prnewswire.com/news-releases/helsinn-group-y-eisai-inc-anuncian-los-resultados-de-primera-linea-para-ensayos-pivote-con-netupitant-y-palonosetron-207717391.html Thu, 16 May 2013 11:27:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-survey-results-from-3000-postmenopausal-women-living-with-vulvar-and-vaginal-atrophy-207713721.html http://www.prnewswire.com/news-releases/new-survey-results-from-3000-postmenopausal-women-living-with-vulvar-and-vaginal-atrophy-207713721.html Thu, 16 May 2013 11:03:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/lakewood-amedex-announces-results-demonstrating-the-more-rapid-direct-bactericidal-activity-of-novel-bisphosphocin-class-of-antimicrobials-207705131.html http://www.prnewswire.com/news-releases/lakewood-amedex-announces-results-demonstrating-the-more-rapid-direct-bactericidal-activity-of-novel-bisphosphocin-class-of-antimicrobials-207705131.html Thu, 16 May 2013 10:15:00 EDT en-US PR Newswire Association LLC.